NEW YORK (GenomeWeb News) – Danaher has reaffirmed its net earnings guidance for the fourth quarter and full-year 2012 and provided 2013 guidance in advance of its investor meeting to be held today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.